Items where authors include "Distler, O"
Up a levelArticle
Shinjo, SK, Kim, M, Hoff, LS et al. (32 more authors) (2023) Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study. International Journal of Rheumatic Diseases. ISSN 1756-1841
Hoffmann-Vold, A-M, Brunborg, C, Airò, P et al. (13 more authors) (2023) Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research. Chest, 163 (3). pp. 586-598. ISSN 0012-3692
Sen, P, Naveen, R, Houshmand, N et al. (53 more authors) (2023) Vaccine hesitancy decreases, long term concerns remain in myositis, rheumatic disease patients: A comparative analysis of the COVAD surveys. Rheumatology. kead057. ISSN 1462-0324
Hoff, LS, Ravichandran, N, Shinjo, SK et al. (39 more authors) (2023) COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey. Rheumatology International, 43 (1). pp. 47-58. ISSN 0172-8172
Sen, P, Ravichandran, N, Nune, A et al. (27 more authors) (2023) COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study. Rheumatology, 62 (1). pp. 65-76. ISSN 1462-0324
Fazal, ZZ, Sen, P, Joshi, M et al. (33 more authors) (2022) COVAD survey 2 long-term outcomes: unmet need and protocol. Rheumatology International, 42 (12). pp. 2151-2158. ISSN 0172-8172
R, N, Nikiphorou, E, Joshi, M et al. (23 more authors) (2022) Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study. Rheumatology. keac661. ISSN 1462-0324
Naveen, R, Parodis, I, Joshi, M et al. (21 more authors) (2022) COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis. Rheumatology. keac624. ISSN 1462-0324
Dey, M, Naveen, R, Nikiphorou, E et al. (92 more authors) (2022) Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study. Rheumatology. keac603. ISSN 1462-0324
Gil‐Vila, A, Naveen, R, Selva‐O'Callaghan, A et al. (32 more authors) (2022) COVID‐19 Vaccination In Autoimmune Diseases (COVAD) Study: Vaccine Safety In Idiopathic Inflammatory Myopathies. Muscle & Nerve, 66 (4). pp. 426-437. ISSN 0148-639X
Yoshida, A, Kim, M, Kuwana, M et al. (30 more authors) (2022) Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey. Rheumatology. keac441. ISSN 1462-0324
Tan, AL orcid.org/0000-0002-9158-7243, Sen, P, Gupta, L et al. (23 more authors) (2022) Vaccine Hesitancy in Patients with Autoimmune Diseases Data from the Coronavirus Disease-2019 Vaccination in Autoimmune Diseases Study. Indian Journal of Rheumatology, 17 (2). pp. 188-191. ISSN 0973-3698
Sen, P, Gupta, L, Lilleker, JB et al. (82 more authors) (2022) COVID-19 vaccination in autoimmune disease (COVAD) survey protocol. Rheumatology International, 42 (1). pp. 23-29. ISSN 0172-8172
Bellando-Randone, S, Del Galdo, F orcid.org/0000-0002-8528-2283, Lepri, G et al. (13 more authors) (2021) Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS). The Lancet Rheumatology, 3 (12). e834-e843. ISSN 2665-9913
Kocher, A, Ndosi, M, Denhaerynck, K et al. (9 more authors) (2021) A rare disease patient-reported outcome measure: revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) using the Rasch model. Orphanet Journal of Rare Diseases, 16 (1). 356. 356-. ISSN 1750-1172
Allanore, Y, Bozzi, S, Terlinden, A et al. (14 more authors) (2020) Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database. Arthritis Research and Therapy, 22. 257. ISSN 1478-6354
Hoffmann-Vold, A-M, Maher, TM, Philpot, EE et al. (29 more authors) (2020) The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. Lancet Rheumatology, 2 (2). E71-E83. ISSN 2665-9913
Blagojevic, J, Bellando-Randone, S, Abignano, G et al. (22 more authors) (2019) Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey. Arthritis Research & Therapy, 21 (1). 35. ISSN 1478-6354
Sobanski, V, Giovannelli, J, Allanore, Y et al. (10 more authors) (2019) Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis. Arthritis and Rheumatology, 71 (9). pp. 1553-1570. ISSN 2326-5191
Abignano, G, Blagojevic, J, Bissell, L-A orcid.org/0000-0002-2789-4652 et al. (16 more authors) (2019) European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis. Rheumatology, 58 (2). key271. pp. 254-259. ISSN 1462-0324
Jaeger, VK, Valentini, G, Hachulla, E et al. (22 more authors) (2018) Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study. Arthritis and Rheumatology, 70 (11). pp. 1829-1834. ISSN 2326-5191
Herrick, AL, Peytrignet, S, Lunt, M et al. (29 more authors) (2018) Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European scleroderma observational study. Annals of the Rheumatic Diseases, 77 (4). pp. 563-570. ISSN 0003-4967
Jaeger, VK, Distler, O, Maurer, B et al. (37 more authors) (2018) Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology, 57 (3). pp. 441-450. ISSN 1462-0324
Peytrignet, S, Denton, CP, Lunt, M et al. (60 more authors) (2018) Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study. Rheumatology, 57 (2). pp. 370-381. ISSN 1462-0324
Herrick, AL, Pan, X, Peytrignet, S et al. (61 more authors) (2017) Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Annals of the Rheumatic Diseases, 76 (7). pp. 1207-1218. ISSN 0003-4967
Jaeger, VK, Wirz, EG, Allanore, Y et al. (96 more authors) (2016) Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study. PLOS ONE, 11 (10). e0163894.
Wirz, EG, Jaeger, VK, Allanore, Y et al. (15 more authors) (2015) Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Annals of the Rheumatic Diseases, 75 (7). pp. 1285-1292. ISSN 0003-4967
Conference or Workshop Item
Sen, P, R, N, Nune, A et al. (26 more authors) (2022) COVID-19 VACCINATION-RELATED ADVERSE EVENTS AMONG AUTOIMMUNE DISEASE PATIENTS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Grignaschi, S, Cavagna, L, Kim, M et al. (28 more authors) (2022) HIGH FATIGUE SCORES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A MULTIGROUP COMPARATIVE STUDY FROM THE COVAD E-SURVEY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Yoshida, A, Kim, M, Kuwana, M et al. (29 more authors) (2022) IMPAIRED PROMIS PHYSICAL FUNCTION IN IDIOPATHIC INFLAMMATORY MYOPATHY PATIENTS: RESULTS FROM THE MULTICENTER COVAD PATIENT REPORTED E-SURVEY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Gupta, L, Hoff, LS, R, N et al. (28 more authors) (2022) POS0201 COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN IDIOPATHIC INFLAMMATORY MYOPATHIES, OTHER SYSTEMIC AUTOIMMUNE AND INFLAMMATORY DISEASES, AND HEALTHY INDIVIDUALS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASES (COVAD) STUDY. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2021, Copenhagen, Denmark.
Aoude, M, Gupta, L, Hmamouchi, I et al. (30 more authors) (2022) TREATMENT PATTERNS OF IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM AN INTERNATIONAL COHORT OF OVER 1,400 PATIENTS. In: EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark.
Proceedings Paper
R, N, Joshi, M, Sen, P et al. (39 more authors) (2022) Vaccine Hesitancy Among Patients with Idiopathic Inflammatory Myopathies and Rheumatic Diseases in 2021-2022: A Comparative Analysis of COVID-19 Vaccination in Autoimmune Diseases Surveys. In: Arthritis and Rheumatology. ACR Convergence 2022, 10-14 Nov 2022, Philadelphia, USA. Wiley , pp. 3717-3720.